To schedule a 1x1 meeting with the Company, please email corporateaccess@psc.com.
About ANI
Investor Relations:
T: 212-452-2793
E: lwilson@insitecony.com
Source:
Source:
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.62 USD | -1.65% | -1.35% | +19.01% |
03/05 | Ani Pharmaceuticals Insider Sold Shares Worth $1,332,400, According to a Recent SEC Filing | MT |
17/04 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
To schedule a 1x1 meeting with the Company, please email corporateaccess@psc.com.
About ANI
Investor Relations:
T: 212-452-2793
E: lwilson@insitecony.com
Source:
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+19.01% | 1.38B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.92% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |